DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

December 10, 2024 11:00 AM

MMJ International Holdings has taken a significant step forward by submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its novel cannabis-derived medication. This significant move anticipates FDA approval to initiate comprehensive clinical trials, focusing on the treatment of chorea associated with Huntington's disease (HD). This step is a testament to MMJ's dedication to harnessing the...

Read more

UNOS CEO Urges Congressional Action on Lifesaving Reforms

December 10, 2024 10:55 AM

RICHMOND, VA / ACCESSWIRE / December 10, 2024 / Maureen McBride, Ph.D., the CEO of the United Network for Organ Sharing (UNOS), sent a letter to Congress requesting action on a slate of reforms to our nation's organ donation and transplantation system that will remove barriers, increase efficiency, and reduce organ non-use to help save more lives.The letter was sent to members of the House Committee on Energy and Commerce, which has oversight...

Read more

Tallahassee Plastic Surgery Clinic Launches Nouvo Med Spa - Area's Newest Destination in Non-Invasive Aesthetic Care

December 10, 2024 10:00 AM

TALLAHASSEE, FL / ACCESSWIRE / December 10, 2024 / Tallahassee Plastic Surgery Clinic has introduced Nouvo Med Spa, an advanced medical spa offering cutting-edge non-surgical aesthetic treatments under the guidance of the clinic's experienced plastic surgeons. Located at 2458 Mahan Drive, Suite 103, Nouvo Med Spa offers non-invasive cosmetic and aesthetic services in a modern, inviting setting as a complement to the services offered by...

Read more

Vheda Health Achieves I1 HITRUST Certification

December 10, 2024 10:00 AM

Vheda Health, a leader in virtual health engagement for underserved populations, is proud to announce it has achieved i1 HITRUST certification, the industry's most rigorous standard for healthcare security. This milestone reflects Vheda Health's ongoing commitment to safeguarding the privacy and data of its health plan partners and their members, providing an added layer of confidence to clients relying on the security and reliability of its...

Read more

Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne

December 10, 2024 9:00 AM

SAN DIEGO, CA / ACCESSWIRE / December 10, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced receipt of a notice of allowance from the United States Patent and Trademark Office of a new patent for its DMT310 product candidate for the treatment of acne. The allowed patent...

Read more

Dr. Amir Bajoghli and Team Publish New Case Study on Aquagenic Urticaria in BMJ Journals

December 10, 2024 9:00 AM

MCLEAN, VA / ACCESSWIRE / December 10, 2024 / Dr. Amir Bajoghli and his colleagues have recently published an insightful case study in BMJ Journals, titled "Aquagenic Urticaria in an Adolescent: Differential Diagnosis and Management." The study examines a rare case of aquagenic urticaria and underscores the importance of accurate diagnosis and effective management strategies for this unusual condition.Aquagenic urticaria is a rare form of...

Read more

Dr. Sindhu Srinivas Joins Ankle & Foot Centers of America

December 10, 2024 9:00 AM

Ankle & Foot Centers of America announces that Dr. Sindhu Srinivas, a podiatrist, fellowship-trained ankle and foot surgeon and specialist in lower-limb salvage, has joined its physician team.Ankle & Foot Centers of America is one of the nation's leading podiatry groups, founded in the Atlanta area in 1982 and with 40 locations across Georgia. Its team of more than 40 board-certified, highly skilled foot and ankle surgeons provide services...

Read more

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End

December 10, 2024 8:30 AM

MIAMI, FL / ACCESSWIRE / December 10, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company, proudly announces the successful completion of its current Good Laboratory Practice (GLP) preclinical safety program for Ketamir-2, a novel oral ketamine analog. The results confirm no adverse findings, clearing a critical milestone as the Company progresses toward submitting its Investigational New Drug (IND)...

Read more

Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product

December 10, 2024 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced the receipt of commitment of future supply of GMP nafamostat, a critical component of PF614-MPAR. This agreement fully secures the supply chain and allows Ensysce to reference the nafamostat Drug Master File of...

Read more

Ignite Biomedical Achieves Key Milestone in Precision Medicine with Successful Analytical Validation of TNF-alpha Inhibitor Treatment Response Predictor

December 10, 2024 8:00 AM

Ignite Biomedical, Inc. ("Ignite"), a leader in AI-driven biomarker innovation for precision medicine, today announced the successful completion of analytical validation for its Tumor Necrosis Factor-alpha Inhibitor (TNFi) Treatment Response Predictor (TRP). This achievement marks a pivotal inflection point in the development of Ignite's precision medicine portfolio, demonstrating its commitment to advancing patient-specific treatments....

Read more

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

December 10, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / December 10, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd., that the safety review committee recommends commencing dosing of the second cohort in its trial entitled "A Phase 1,...

Read more

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

December 10, 2024 7:30 AM

KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI). VisiRose, a newly launched company of Provectus...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards

December 10, 2024 7:00 AM

AUSTIN, TX / ACCESSWIRE / December 10, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company received a letter from the Staff at Nasdaq Listings Qualifications stating that the Company has regained compliance with Listing Rule 5550(a)(2), which specifies rules regarding a minimum bid price of $1.00.Trent Ward,...

Read more

Heart Failure and other Cardiovascular Diseases Propels the demand for Cardiac Rhythm Management Market Get Detailed Analysis by FMI

December 10, 2024 5:00 AM

The Cardiac Rhythm Management Market is on track for significant growth, with its valuation expected to increase from USD 24.7 billion in 2024 to USD 36.7 billion by 2034, representing a compound annual growth rate (CAGR) of 4% over the forecast period. The growth is being driven by the rising incidence of cardiac arrhythmias, heart failure, and other cardiovascular disorders. This surge in demand for cardiac rhythm management devices highlights...

Read more

Jolt Health Inc. Announces Availability of Meeting Materials

December 9, 2024 8:10 PM

VANCOUVER, BC / ACCESSWIRE / December 9, 2024 / Jolt Health Inc. (CSE:JOLT) ("Jolt" or the "Company") announces that in connection with the ongoing Canada Post labour strike, the notice of meeting, management information circular, and form of proxy (the "Meeting Materials") for the upcoming annual general and special meeting (the "Meeting") of the shareholders (the "Shareholders") of the Company, can be accessed under Jolt's SEDAR+ profile on...

Read more

ASBM Responds to PCMA: Put Patients First, Not PBM Profits

December 9, 2024 7:15 PM

As the Senate moves this week to advance passage of the misleadingly named Biosimilar Red Tape Elimination Act (S. 2035), the Alliance for Safe Biologic Medicines (ASBM) reiterates its opposition to the self-interested efforts of the Pharmaceutical Care Management Association (PCMA), which strongly supports this bill that prioritizes insurance company and pharmacy benefit manager (PBM) profits over patient safety and maintaining physician trust....

Read more

Black Book Highlights Global Surge in Cybersecurity Attacks Threatening Healthcare Systems Worldwide: UK, Australia, India, and Brazil Among Top Targets

December 9, 2024 7:00 PM

MELBOURNE, AUSTRALIA / ACCESSWIRE / December 9, 2024 / Healthcare systems worldwide are grappling with a sharp rise in ransomware attacks, endangering patient care, operational stability, and data security. According to Black Book Research, 81% of global healthcare organizations surveyed have reported data security incidents since 2022-the highest rate in over a decade. Non-U.S. hospitals face significant financial strain, with recovery costs...

Read more

Morpheus8 Newport Beach Doctor Helps Fade Wrinkles and Fine Lines

December 9, 2024 6:43 PM

Finding effective treatments for wrinkles and fine lines is a common goal for many seeking a youthful appearance, and Morpheus8 might be the answer for those wanting to fade facial wrinkles and fine lines. This advanced procedure combines microneedling with radiofrequency energy, offering solutions for tightening loose skin and reducing visible signs of aging. Morpheus8 effectively targets problem areas, providing noticeable improvements in skin...

Read more

Sun Knowledge Inc. Revolutionizes Revenue Cycle Management with Comprehensive Solutions

December 9, 2024 4:10 PM

NEW YORK CITY, NY / ACCESSWIRE / December 9, 2024 / Sun Knowledge Inc. - a Revenue Cycle Management pioneer - is pleased to introduce its sophisticated and consolidated service solutions that enable healthcare service providers to make their day-to-day operations more effective, increase reimbursements and minimize administrative pressure. Helping both providers and payers with solutions, Sun Knowledge brings high-end technology together with...

Read more

Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable Hematocrit Control at the ASH 2024 Annual Meeting

December 9, 2024 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced details from a poster presentation with final data from the rusfertide Phase 2 REVIVE study. Rusfertide, a mimetic of the natural hormone hepcidin, has potential therapeutic value in the treatment of polycythemia vera (PV) and other disease indications. The data were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place...

Read more